AAPP Scientific Poster Session Abstracts
Currently Viewing Abstracts from 2011
2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026
| Title | Presenter | Type | Session |
|---|---|---|---|
A comprehensive review of ziprasidone and the QTc Interval
|
Kobes, Rodger | Encore Presentation | Session 1 |
|
A Cross Country Study of The Effect of Three Dibenzodiazepines: Clozapine, Quetiapine And Olanzepine On Thyroid Function In Patients With Schizophrenia
|
Yuan, Xiaojuan (Carol) | Work in Progress | Session 2 |
|
A POOLED ANALYSIS OF THE EFFECTS OF ASENAPINE ON THE PERSISTENT NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
|
Mackle, Mary | Encore Presentation | Session 2 |
|
A Review of Behavioral Health Inpatients Discharged on Two or More Antipsychotic Medications
|
Gagne, Hatice | Work in Progress | Session 1 |
|
Abnormal Triiodothyronine Levels in a 12 Year Old on Lithium
|
Price, Paul | Encore Presentation | Session 2 |
|
ADHERENCE AND CLINICAL OUTCOME OF METABOLIC MONITORING IN PSYCHIATRIC PATIENTS TRANSITIONING FROM AN INPATIENT TO OUTPATIENT SETTING
|
Deardorff, Orlen | Work in Progress | Session 1 |
|
Adherence to Selective Serotonin Reuptake Inhibitors in OEF/OIF Veterans with Mental Health Disorders: The Impact of Pharmacist Services
|
Burke, Brenda | Work in Progress | Session 2 |
|
AGRANULOCYTOSIS ASSOCIATED WITH PSYCHOTROPIC MEDICATIONS: A FATAL CASE
|
Shankar, Gollapudi | Therapeutic Case Report | Session 2 |
|
ALL CAUSE MORTALITY IN OLDER VETERANS WITH DEMENTIA ON LONG-TERM ATYPICAL ANTIPSYCHOTICS
|
Stanley, Matthew | Original Research | Session 2 |
|
An Evaluation of the Comparative Risks of Atypical Antipsychotics used for Augmentation in Major Depressive Disorder (MDD)
|
Tulio R. Ortega, Terrance J. Bellnier | Original Research | Session 2 |
|
An Instrument for Measuring Pharmacist and Physician Attitudes Toward Collaboration: Preliminary Psychometric Data
|
Justino, Pharm D., BCPP, J. Daniel | Encore Presentation | Session 2 |
|
Anticholinergic Burden and Risk of Mechanical Falls in an Elderly Asian American Community Dwelling Population
|
Hoffman, Janice | Original Research | Session 1 |
|
ANTIPSYCHOTIC MEDICATIONS AND THE DEVELOPMENT OF PNEUMONIA IN PERSONS DIAGNOSED WITH SCHIZOPHRENIA
|
Brahm, Nancy | Original Research | Session 2 |
|
Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia
|
Kelly, Deanna | Encore Presentation | Session 1 |
|
ARE PROVIDERS DOCUMENTING THE EFFICACY OF ARIPIPRAZOLE FOR ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER AFTER 3 MONTHS OF TREATMENT?
|
Gouker, Michelle | Work in Progress | Session 2 |
|
ARIPIPRAZOLE-INDUCED HYPERTENSIVE CRISIS: A CASE SERIES
|
Hepfer, K Sloan | Therapeutic Case Report | Session 1 |
|
ARIPIPRAZOLE: A REVIEW FOR EFFICACY IN METHAMPHETAMINE USE COMORBIDITIES IN TWO PSYCHIATRIC PATIENT POPULATIONS
|
Brackins, Todd | Work in Progress | Session 1 |
|
ASSESSMENT OF ADHERENCE WITH METABOLIC MONITORING BEFORE AND AFTER IMPLEMENTATION OF A PHARMACY-DRIVEN COMPUTERIZED METABOLIC MONITORING DATABASE
|
Canning, Jacquelyn | Work in Progress | Session 1 |
|
Assessment of Medication Adherence in an Immigrant/Refugee Psychiatric Patient Population
|
Gable, Kelly | Work in Progress | Session 2 |
|
Assessment of Prophylactic Clozapine Levels in Stable Outpatients with Schizophrenia and Schizoaffective Disorder
|
Wilborn, Courtney | Work in Progress | Session 1 |
|
Assessment of Psychotropic Drug Abuse in an Adolescent Substance Dependent Population and Evaluation of Associated Prescriber Perceptions
|
Holmes, Jamie | Work in Progress | Session 2 |
Assessment of Tobacco Craving in Smokers with Schizophrenia using Virtual Reality
|
Wehring, Heidi | Encore Presentation | Session 2 |
|
Association between LEP -2548 (rs7799039) and obesity during antipsychotic treatment
|
Bishop, Jeffrey | Encore Presentation | Session 1 |
|
Atomoxetine in adults with attention-deficit/hyperactivity disorder: A 24-week, randomized, double-blind, placebo-controlled trial
|
Zappone, Colin | Encore Presentation | Session 2 |
|
Attitudes and expectations of individuals with schizophrenia and schizoaffective disorder toward pharmacists.
|
Hoch, Matt | Original Research | Session 1 |
|
ATYPICAL ANTIPSYCHOTIC POLYPHARMACY: ARE SAFETY AND ECONOMIC CONCERNS REALLY A REASON TO AVOID ATYPICAL ANTIPSYCHOTIC COMBINATION THERAPY?
|
Graham, Rebecca | Work in Progress | Session 1 |
|
Buprenorphine-naloxone for the office-based treatment of opiate addiction in patients with psychiatric co-morbidities
|
Acosta, Ashley | Work in Progress | Session 1 |
|
Cardiometabolic Impact of Second Generation Antipsychotics in the Pediatric Population: Implications for Future Prescribing Practices of Antipsychotics in Children
|
Allen, Shari | Work in Progress | Session 2 |
|
Cardiovascular Risk Profile of Patients with Severe Mental Illness
|
Zolezzi, Monica | Original Research | Session 1 |
|
CHANGE IN STUDENTS' KNOWLEDGE AND ATTITUDES AFTER PARTICIPATING IN AN ALCOHOL AND OTHER DRUG DEPENDENCIES ELECTIVE
|
Brahm, Nancy | Encore Presentation | Session 2 |
|
Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder
|
Ebong, Ekaette | Work in Progress | Session 1 |
|
Clinical Management of Metabolic Syndrome: Does Mental Illness impact care?
|
Hughes, Caitlin | Work in Progress | Session 1 |
|
CLOZAPINE POINT OF CARE TESTING AT AN INDEPENDENT MENTAL HEALTH PHARMACY
|
leland, rob | Innovative Practices | Session 1 |
|
Clozapine-induced hiccups and facial tics in a schizophrenic patient : a case report
|
Auclair, Marie | Therapeutic Case Report | Session 2 |
|
COLLABORATIVE DRUG THERAPY MANAGEMENT FOR BUPRENORPHINE- MAINTAINED PATIENTS
|
DiPaula, Bethany | Innovative Practices | Session 2 |
|
Comparison of hospitalisation time of schizophrenic patients exposed and not exposed to therapeutic drug monitoring of clozapine
|
Vincent, Philippe | Original Research | Session 1 |
|
Comparison of Long Acting Antipsychotic Injections to the Oral Equivalents and the Impact on Recidivism
|
Jhawar, Archana | Work in Progress | Session 1 |
|
Considering Cytochrome P450 Genotyping Results During Clinical Psychopharmacology Consultation
|
Caley, Charles | Innovative Practices | Session 1 |
|
CPNP Student Chapter fills a void for students interested in psychiatric pharmacy
|
Thedford, Sheryl | Innovative Practices | Session 1 |
|
Creation and Implementation of a Psychopharmacology Consult Team to Improve Outcomes in the Severely Mentally Ill Population
|
Bogart, Greg | Work in Progress | Session 1 |
|
DESIGN AND IMPLEMENTATION OF A CLINICAL PHARMACIST MANAGED METABOLIC SYNDROME CLINIC IN A MENTAL HEALTH SETTING
|
DeJongh, Beth | Work in Progress | Session 2 |
|
Developing an interdisciplinary pharmacogenomic treatment approach to reduce medication burden and improve subject outcomes
|
Bradley, Bridget | Work in Progress | Session 2 |
|
Development of Psychotropic Medication Utilization Parameters for Foster Children.
|
Crismon, M. Lynn | Innovative Practices | Session 2 |
|
DISASTER IMPACT ON THE PSYCHIATRIC PATIENT: A PREPAREDNESS TOOLKIT
|
Brahm, Nancy | Innovative Practices | Session 2 |
|
Double-Blind, Placebo-Controlled Efficacy and Safety Study of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
|
Shepski, John | Encore Presentation | Session 2 |
|
Drug assay monitoring in psychiatric inpatients: evaluation of a pharmacist verification process for lithium and valproic acid laboratory orders
|
Allen, Brittany | Work in Progress | Session 1 |
|
Drug Utilization Evaluation of Patient Variables Leading to the Administration of Olanzapine Orally-Disintegrating Tablets for Acute Agitation in a Community Hospital
|
Powell, Hillary | Encore Presentation | Session 2 |
|
EARLY IMPROVEMENT PREDICTS LATER OUTCOME IN MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER: POST HOC ANALYSES OF ASENAPINE STUDIES
|
Mackle, Mary | Original Research | Session 2 |
|
Effect of Adjunctive Aripiprazole on Domains of Functioning in Patients with Major Depressive Disorder: a Pooled Analysis of Three Clinical Trials
|
Ammerman, Diane | Encore Presentation | Session 1 |
|
EFFECT OF CLINICAL PHARMACIST INVOLVEMENT WITH THE MENTAL HEALTH INTENSIVE CASE MANAGEMENT (MHICM) TEAM AT VA SAN DIEGO HEALTHCARE SYSTEM
|
McCue, Michele | Work in Progress | Session 1 |
|
Effect of Duloxetine 30mg and 60mg on the Pupillary Light Reflex as Compared with Placebo
|
VanDenBerg, Chad | Encore Presentation | Session 2 |
|
EFFECT OF FOOD ON THE PHARMACOKINETICS OF SUBLINGUAL ASENAPINE
|
Mackle, Mary | Encore Presentation | Session 2 |
|
Effect of prior antipsychotic exposure on weight gain during aripiprazole treatment of irritability associated with autistic disorder
|
Stockton, Gwen | Encore Presentation | Session 1 |
|
Effects of Pharmacist Quarterly Drug Regimen Reviews on Physician Compliance with Recommended Laboratory Monitoring Parameters for Psychotropic Medications at a State Supported Living Center
|
Farinde, Abimbola | Work in Progress | Session 2 |
|
Efficacy of Memantine by Baseline Disease Severity: Post-hoc Analysis of Pooled Trials in Patients with Mild to Moderate Alzheimers Disease
|
Tocco, Michael | Encore Presentation | Session 1 |
|
Efficacy of Memantine in Moderate to Severe Alzheimers Disease: Time-to-Event Analysis in a Pooled Population
|
Tocco, Michael | Encore Presentation | Session 1 |
|
Endothelial Functioning and Omega 3 Fatty Acids in Schizophrenia Subjects Receiving Antipsychotics
|
Gardner, Kristin Gardner, Pharm.D. Candidate | Encore Presentation | Session 2 |
|
EVALUATING AND PREVENTING MEDICATION ERRORS IN A MENTAL HEALTH FACILITY-WHAT IS THE PHARMACIST ROLE?
|
Woodard, Todd | Work in Progress | Session 2 |
|
Evaluating the Effect of Concomitant Medications With Clozapine
|
Black Proctor, RPh, Gail | Original Research | Session 2 |
|
Evaluation of antidepressant prescribing and management between primary care physicians and psychiatrists and the adherence to treatment guidelines
|
Mitchell, Brian | Work in Progress | Session 2 |
|
EVALUATION OF ARIPIPRAZOLE UTILIZATION FOR AUGMENTATION OF ANTIDEPRESSANT PHARMACOTHERAPY
|
Mitchell, J. Cameron | Work in Progress | Session 2 |
|
Evaluation of Delirium Risk Factors in Patients Undergoing Acute Abdominal Transplants
|
Khorsandi, Pargol | Work in Progress | Session 1 |
|
Evaluation of Fall Rates and Medication Regimens for Patients in an Inpatient Psychiatric versus General Medical-Surgical Ward
|
Henry, Jessica | Work in Progress | Session 2 |
|
Evaluation of perphenazine use in a veteran population
|
Caruana, Stephen | Work in Progress | Session 2 |
|
Evaluation of schizophrenic, schizoaffective, and bipolar patients with exposure to sexual and/or physical abuse and its effect on treatment: a retrospective review
|
Demian, Nancy | Work in Progress | Session 1 |
|
EVALUATION OF SEXUAL FUNCTION IN OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DESVENLAFAXINE OR PLACEBO
|
Clayton, Anita | Encore Presentation | Session 1 |
|
EVALUATION OF THE MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH ALPHA-2-AGONISTS FOR POSTTRAUMATIC STRESS DISORDER IN CHILDREN AND ADOSESCENTS
|
Hepfer, K. Sloan | Work in Progress | Session 1 |
|
Evaluation of Virtual Patient Cases in a Psychiatry Elective Seminar Course
|
Frey, Theresa | Work in Progress | Session 2 |
|
Facilitating the continuum of care for patients unable to take oral psychotropic medications: A case report of transdermal venlafaxine
|
Gonzalez, Misty | Therapeutic Case Report | Session 1 |
|
Fatal Acute Hepatotoxicity Associated with Valproate Initiation in an Adult
|
Kennedy, Klugh | Therapeutic Case Report | Session 2 |
|
Frequency and Type of Interventions Aimed at Reducing Cardiovascular Risk in Mental Health Patients in an Urban Teaching Hospital
|
Lagnado, Gillian | Original Research | Session 2 |
|
Genetic and Environmental Risk Factors for Postpartum Depression
|
Finley, Patrick | Encore Presentation | Session 2 |
|
GRAVES’ HYPERTHYROIDISM-INDUCED PSYCHOSIS TREATED WITH ARIPIPRAZOLE- A CASE REPORT
|
Macedo, Livia | Therapeutic Case Report | Session 2 |
|
HEMATOLOGICAL EFFECTS OF VALPROATE IN A SKILLED NURSING POPULATION
|
Davis, Alan | Work in Progress | Session 1 |
Iloperidone in the Treatment of Seriously Mentally Ill Patients with Treatment-Refractory Schizophrenia and Schizoaffective Disorder: A Case Series
|
Saklad, PharmD, BCPP, Stephen | Therapeutic Case Report | Session 2 |
|
Impact of Educational Interventions on Insight and Attitudes toward Medication in Psychiatric Inpatients
|
Patel, Krina | Original Research | Session 1 |
|
Impact of Pharmacist's Medication Monitoring Program on Antipsychotic Prescribing in a Large Outpatient County Organization
|
Raynor, Charles | Original Research | Session 1 |
|
IMPACT OF PRETREATMENT WITH AMOBARBITAL ON ELECTROCONVULSIVE THERAPY OUTCOMES
|
Ross, Clint | Work in Progress | Session 2 |
|
Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility
|
Bird, Angela | Original Research | Session 1 |
|
IMPROVING MENTAL HEALTH OUTCOMES IN VETERANS THROUGH ACADEMIC DETAILING
|
Christopher, Melissa | Innovative Practices | Session 2 |
|
INCIDENCE, ONSET, AND DURATION OF TREATMENT-EMERGENT SOMNOLENCE WITH ASENAPINE IN PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER
|
Mackle, Mary | Original Research | Session 2 |
|
INCORPORATION OF CLINICAL PHARMACY INTO AN INTEGRATED BEHAVIORAL HEALTH SERVICE IN A FAMILY MEDICINE CLINIC
|
Gallimore, Casey | Work in Progress | Session 2 |
|
INCREASED PATIENT RESPONSE TO INTRAMUSCULAR HALOPERIDOL DECANOATE FOLLOWING A CHANGE IN NEEDLE LENGTH
|
Brahm, Nancy | Therapeutic Case Report | Session 2 |
|
Induction of Drug Efflux Protein Expression by Venlafaxine but not Desvenlafaxine
|
Levin, Gary | Encore Presentation | Session 2 |
|
LEADERSHIP DEVELOPMENT THROUGH A BOOK CLUB USING THE FIVE DYSFUNCTIONS OF A TEAM
|
Kissack, Julie | Work in Progress | Session 1 |
|
Long-Acting Injectable Risperidone versus Oral Risperidone: A Comparison of Recidivism
|
Shults, Jana | Work in Progress | Session 2 |
|
Long-term comparative effectiveness and safety of duloxetine vs. venlafaxine XR in veterans with major depressive disorder
|
Shields, Whitney | Work in Progress | Session 2 |
|
Medication Adherence, Lipid and Glycemic Control in Patients with Psychotic Disorders Compared to Patients without Psychiatric Illness Receiving Care in a Veterans Affairs Medical System
|
Nelson, Leigh Anne | Original Research | Session 1 |
|
META-ANALYSES OF THE EFFICACY OF ASENAPINE VERSUS PLACEBO IN BIPOLAR I DISORDER AS MONOTHERAPY AND ADJUNCT THERAPY COMPARED WITH OTHER ATYPICAL ANTIPSYCHOTICS
|
Mackle, Mary | Encore Presentation | Session 1 |
|
META-ANALYSIS OF THE EFFICACY OF ASENAPINE FOR ACUTE SCHIZOPHRENIA: COMPARISONS WITH PLACEBO AND OTHER ATYPICAL ANTIPSYCHOTICS
|
Mackle, Mary | Encore Presentation | Session 2 |
|
Metabolic adverse effects of second generation antipsychotics in an elderly veteran population
|
Stanley, Matthew | Work in Progress | Session 2 |
|
Metabolic Monitoring and Second Generation Antipsychotic Use: Does Indication Matter?
|
Englett, Brianna | Work in Progress | Session 1 |
|
METABOLIC SYNDROME MONITORING PROGRAM: A CLINICAL PROGRAM TO SCREEN PATIENTS FOR METABOLIC SYNDROME IN A STATE PSYCIATRIC HOSPITAL
|
Riesselman, Amber | Work in Progress | Session 1 |
|
Nova Southeastern CPNP Collegiate Chapter: Activities and Development
|
Messinger, Mackenzie | Innovative Practices | Session 1 |
|
Opiate Use for Chronic Non-malignant Pain
|
Englett, Brianna | Original Research | Session 1 |
|
Pediatricians' Treatment of Children and Adolescents with Major Depressive Disorder
|
Pfalzgraf, Andrea | Original Research | Session 1 |
|
Pharmacist Discharge Counseling: Effects on Discharge Medication Errors on a Behavioral Medicine Unit
|
Striker, Renee | Work in Progress | Session 1 |
|
Pharmacokinetics of Coadministration of Guanfacine Extended Release and Lisdexamfetamine Dimesylate
|
Haffey, Mary | Original Research | Session 1 |
|
Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
|
Haffey, Mary | Original Research | Session 1 |
|
Pharmacologic Management of Intermittent Explosive Disorder with Multiple Comorbidities in an 8 year-old male
|
Maroney, Megan | Therapeutic Case Report | Session 1 |
|
Pharmacotherapeutic Regimens in Patients with Post Traumatic Stress Disorder and Co-morbid Mild Traumatic Brain Injury
|
Morgan, Meghan | Original Research | Session 1 |
|
POOLED ANALYSIS OF ASENAPINE POPULATION PHARMACOKINETICS IN PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
|
Mackle, Mary | Encore Presentation | Session 2 |
|
Preliminary data of metabolic risk at 6-months in subjects on antipsychotic agents: A 12-month randomized multi-centered trial.
|
Schneiderhan, Mark | Work in Progress | Session 1 |
|
Prescribing Patterns in a Corrections Population with Bipolar Disorder
|
Ehret, Megan | Encore Presentation | Session 2 |
|
Primary Care Physician Mental Health Hotline
|
Dugan, Sara | Innovative Practices | Session 2 |
|
PROBABLE QUETIAPINE-MEDIATED PROLONGATION OF THE QT INTERVAL
|
Brahm, Nancy | Encore Presentation | Session 2 |
|
Psychotropic Medication Adherence: Development of an Inmate Interview Process
|
Ehret, Megan | Work in Progress | Session 2 |
|
Rasagiline and Antidepressant Use in Patients With Parkinson Disease: Assessing the Occurrence of Serotonin Toxicity
|
Chen, Jack | Original Research | Session 1 |
|
Retrospective evaluation of metabolic outcomes during treatment with paliperidone and the effects of coprescribed lipid lowering agents
|
Hughes, Kenneth | Encore Presentation | Session 1 |
|
Retrospective Evaluation of the Effectiveness of Paliperidone Palmitate Injection in an Acute Care 33 Bed Adult Inpatient Psychiatric Hospital.
|
Scarpa, Jose | Original Research | Session 1 |
|
Retrospective Review of Neuroleptic Malignant Syndrome with Atypical Antipsychotics
|
Freeland, Kathryn | Work in Progress | Session 1 |
|
RISK OF CARDIOVASCULAR MORBIDITY AND SUDDEN DEATH WITH RISPERIDONE AND PALIPERIDONE TREATMENT: ANALYSIS OF 64 RANDOMIZED, DOUBLE-BLIND TRIALS
|
Xu, Yimei | Original Research | Session 2 |
|
Risk of Falls Associated with Hyponatremia
|
Chopra, Shruti | Work in Progress | Session 2 |
|
Risperidone-Associated Prolactin Elevation And Markers Of Bone Turnover Early In Treatment
|
Bishop, Jeffrey | Therapeutic Case Report | Session 1 |
|
Safety and Tolerability of Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (6-17 years old): Results from a 52-week Open-Label Study
|
Lau, Gina | Encore Presentation | Session 1 |
|
Schizophrenic Patients: Applying Medication Instructions
|
Tangu, Keumboh | Work in Progress | Session 1 |
|
SEVERE HYPOTHYROIDISM PRESENTING AS PSYCHOSIS: A CASE OF MYXEDEMA MADNESS
|
Leung, Jonathan | Therapeutic Case Report | Session 1 |
|
Single Pulse Transcranial Magnetic Stimulation (TMS) Augmentation of Motor Response Using fMRI-Guided Neuronavigation
|
Boggs, Douglas | Encore Presentation | Session 2 |
|
Study of Rehospitalization Rates of Schizophrenic Patients Discharged on Typical versus Atypical Antipsychotics
|
Tangu, Keumboh | Encore Presentation | Session 1 |
|
Survey of Experiential Clerkship Opportunity in Substance Dependence
|
Park, Dongmi | Work in Progress | Session 1 |
|
THE EFFECT OF DESVENLAFAXINE ON COGNITIVE FUNCTIONING IN EMPLOYED OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
|
Reddy, Sujana Reddy, MD, MBA | Encore Presentation | Session 1 |
|
THE EFFECTS OF SUBUNIT STOICHIOMETRY ON CHANNEL RESPONSES TO LIGAND EXPOSURE IN SH-EP1 CELLS EXPRESSING a4b2 NEURONAL NICOTINIC RECEPTORS
|
Stratton, Harrison | Work in Progress | Session 1 |
|
The Efficacy of Melatonin for Sleep Disturbances in Patients with Substance-Related Disorders
|
Dress, Jennifer | Work in Progress | Session 1 |
|
The Efficacy of Melatonin for the Treatment of Sleep Disturbances on a Psychosocial Care Unit
|
Peterson, Jeanne | Work in Progress | Session 2 |
|
The impact Analysis of Non Formulary Drug request in a state psychiatric teaching hospital
|
Tangu, Keumboh | Work in Progress | Session 1 |
|
The Impact of a Pharmacist Assisted Clinic upon Medication Adherence and Quality of Life in Mental Health Patients
|
Lizer, Mitsi | Innovative Practices | Session 1 |
|
THE IMPACT OF DEPRESSION ON THE SUSTAINED VIRAL RESPONSE OF INTERFERON TREATMENT WITH HEPATITIS C
|
Wackernah, Robin | Work in Progress | Session 1 |
|
The impact of initial drug of abuse on long-term abstinence in patients utilizing buprenorphine/naloxone therapy
|
Winistoerfer, Niccole | Work in Progress | Session 2 |
|
The Management of Antipsychotic Treatment Discontinuation and Interruptions using Model-Based Stimulations
|
Sheehan, John | Original Research | Session 2 |
|
The speed of effects of atypical antipsychotic agents on cholesterol.
|
Griffith, June | Therapeutic Case Report | Session 2 |
|
TREATMENT OF SCHIZOPHRENIA AND CO-MORBID DIPHENHYDRAMINE DEPENDENCE WITH CLOZAPINE: A CASE REPORT
|
Grgas, Marina | Therapeutic Case Report | Session 1 |
|
Treatment Outcomes Across a Spectrum of Disease Severity in Subjects With Bipolar I Disorder Treated With Ziprasidone Plus a Mood Stabilizer
|
Kobes, Rodger | Encore Presentation | Session 1 |
|
Utilizing 4th Year Pharmacy Students as the Primary Pharmacy Members within Mental Health Interdisciplinary Teams
|
Mathys, Monica | Innovative Practices | Session 1 |
|
WEIGHT CHANGE AND METABOLIC EFFECTS OF ASENAPINE IN PLACEBO- OR OLANZAPINE-CONTROLLED STUDIES
|
Mackle, Mary | Encore Presentation | Session 2 |
|
Weight Gain and Metabolic Changes in Studies of Aripiprazole for the Treatment of Pediatric Bipolar I Disorder and Adolescent Schizophrenia
|
Murray, Stephen | Encore Presentation | Session 1 |